Section Arrow
PLSE.NASDAQ
- Pulse Biosciences
Quotes are at least 15-min delayed:2025/09/16 23:15 EDT
Regular Hours
Last
 16.64
+0.9 (+5.72%)
Day High 
16.8 
Prev. Close
15.74 
1-M High
17.342 
Volume 
299.35K 
Bid
15.31
Ask
17.49
Day Low
15.47 
Open
15.56 
1-M Low
13.83 
Market Cap 
1.06B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 15.05 
20-SMA 15.57 
50-SMA 15.49 
52-W High 25 
52-W Low 13.7658 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.08/-1.44
Enterprise Value
1.07B
Balance Sheet
Book Value Per Share
1.55
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BNGOBionano Genomics Inc1.78-0.99-35.74%0.02PE
HBIOHarvard Bioscience0.4849+0.0454+10.33%-- 
AVTRAvantor12.71+0.32+2.58%12.27PE
BAXBaxter International23.87+0.07+0.29%140.32PE
MBOTMicrobot Medical3.34-0.08-2.34%-- 
Quotes are at least 15-min delayed:2025/09/16 23:15 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.